Ally Bridge Group (NY) LLC Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001822947

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q3 2026 · 17 positions · Total reported value $75.30M · Top-10 concentration 88.8% · Updated 2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

Turnover: 75.9% · 4 new · 6 cut · 12 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -15.8% · vs SPY -17.9% · Prev Value $113.07M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -16.4% · vs SPY -18.5% · Latest Value $75.30M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2026 13F filing, Ally Bridge Group (NY) LLC disclosed 17 equity positions with a combined reported value of $75.30M. The filing implies a focused portfolio: its ten largest positions account for 88.8% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2026 were DFTX ($15.22M), ABVX ($12.38M), EWTX ($7.53M). By sector, the heaviest allocations are Health Care 100.0%.

Versus the prior quarter, Ally Bridge Group (NY) LLC opened 4 new positions, trimmed 6 and fully exited 12, a turnover rate of 75.9% of positions. The portfolio's overlap with the prior quarter was 45% of names.

The largest new positions opened in Q3 2026 were AMLX ($5.30M), STTK ($4.26M), VRDN ($4.15M).

Of the 12 positions fully exited versus the prior quarter, the largest were TRAX ($5.72M), AXSM ($4.04M), WHWK ($3.75M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • AMLX AMYLYX PHARMACEUTICALS INC · $5.30M
  • STTK SHATTUCK LABS INC · $4.26M
  • VRDN VIRIDIAN THERAPEUTICS INC · $4.15M
  • CMPX COMPASS THERAPEUTICS INC · $2.08M

Fully Exited (vs previous quarter)

  • TRAX FIRST TRACKS BIOTHERAPEUTICS · prev qtr: $5.72M
  • AXSM AXSOME THERAPEUTICS INC. · prev qtr: $4.04M
  • WHWK WHITEHAWK THERAPEUTICS INC · prev qtr: $3.75M
  • CLYM CLIMB BIO INC · prev qtr: $3.25M
  • KURA KURA ONCOLOGY INC · prev qtr: $3.18M
  • CTMX CYTOMX THERAPEUTICS INC. · prev qtr: $2.91M
  • PALI PALISADE BIO INC · prev qtr: $2.57M
  • SLDB SOLID BIOSCIENCES INC · prev qtr: $2.56M

Insider Transactions (Form 4)

Latest Ally Bridge Group (NY) LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Ally Bridge Group (NY) LLC is an SEC-registered 13F filer based in New York, NY, United States. As of Q3 2026 it reported 17 US equity positions with a combined value of $75.30M. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-121984 (status: Approved), registered 2021-07-30
  • Regulatory AUM (Form ADV): $218.95M as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 3 private funds, of which 3 hedge funds

Portfolio Structure

  • 17 positions · $75.30M reported value (Q3 2026)
  • Top 10 holdings = 88.8% of reported value
  • Largest position: DFTX (DEFINIUM THERAPEUTICS INC) at 20.2%
  • Average position size: $4.43M

Sector Tilt

  • Health Care 100.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q3 2026: 4 new, 2 added, 6 reduced, 12 exited
  • 5 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 100.0%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 400.00K $15.22M 20.22%
20.22%
Hold
2 125.00K $12.38M 16.44%
16.44%
Hold
3 185.43K $7.53M 10.00%
10.00%
Add
4 620.32K $6.73M 8.94%
8.94%
Hold
5 1.66M $5.55M 7.37%
7.37%
Reduce
6 182.00K $5.30M 7.03%
7.03%
New
7 625.19K $4.26M 5.66%
5.66%
New
8 302.45K $4.15M 5.51%
5.51%
New
9 400.00K $2.96M 3.92%
3.92%
Add
10 526.32K $2.80M 3.72%
3.72%
Hold
11 231.12K $2.10M 2.79%
2.79%
Reduce
12 2.00M $2.08M 2.76%
2.76%
New
13 134.43K $2.06M 2.74%
2.74%
Reduce
14 227.25K $838.55K 1.11%
1.11%
Reduce
15 786.24K $466.87K 0.62%
0.62%
Hold
16 163.63K $449.99K 0.60%
0.60%
Reduce
17 18.30K $429.82K 0.57%
0.57%
Reduce

FAQ

What did Ally Bridge Group (NY) LLC buy in 2026-Q3?

In its 2026-Q3 13F filing, Ally Bridge Group (NY) LLC reported 17 equity positions worth $75.30M in aggregate; its largest disclosed positions were DFTX ($15.22M), ABVX ($12.38M), EWTX ($7.53M).

How large is Ally Bridge Group (NY) LLC's portfolio?

Ally Bridge Group (NY) LLC reported $75.30M of long equity holdings across 17 positions as of 2026-Q3. Top-10 holdings account for 88.8% of reported value.

What is Ally Bridge Group (NY) LLC's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/ally-bridge-group-ny/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →